Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

77 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Low-dose irradiation of the gut improves the efficacy of PD-L1 blockade in metastatic cancer patients.
Chen J, Levy A, Tian AL, Huang X, Cai G, Fidelle M, Rauber C, Ly P, Pizzato E, Sitterle L, Piccinno G, Liu P, Durand S, Mao M, Zhao L, Iebba V, Felchle H, Mallard de La Varende AL, Fischer JC, Thomas S, Greten TF, Jones JC, Monge C, Demaria S, Formenti S, Belluomini L, Dionisi V, Massard C, Blanchard P, Robert C, Quevrin C, Lopes E, Clémenson C, Mondini M, Meziani L, Zhan Y, Zeng C, Cai Q, Morel D, Sun R, Laurent PA, Mangoni M, Di Cataldo V, Arilli C, Trommer M, Wegen S, Neppl S, Riechelmann RP, Camandaroba MP, Neto ES, Fournier PE, Segata N, Holicek P, Galluzzi L, Buqué A, Alves Costa Silva C, Derosa L, Kroemer G, Chen C, Zitvogel L, Deutsch E. Chen J, et al. Among authors: di cataldo v. Cancer Cell. 2025 Mar 10;43(3):361-379.e10. doi: 10.1016/j.ccell.2025.02.010. Cancer Cell. 2025. PMID: 40068595 Free article.
Docetaxel in Castration-Resistant Prostate Cancer: A Single-Centre Experience.
Detti B, Franceschini D, Saieva C, Di Brina L, Baki M, Meattini I, Di Cataldo V, Pasquetti EM, Furfaro I, Mancuso A, Simontacchi G, Livi L. Detti B, et al. Among authors: di brina l, di cataldo v. Cancer Invest. 2015;33(7):329. doi: 10.3109/07357907.2015.1060063. Epub 2015 Jul 2. Cancer Invest. 2015. PMID: 26135542 No abstract available.
Stem cell tracking: toward clinical application in oncology?
Mangoni M, Livi L, Biti G, Di Cataldo V, Capaccioli N, Castier Y, Loriot Y, Mordant P, Deutsch E. Mangoni M, et al. Among authors: di cataldo v. Tumori. 2012 Sep-Oct;98(5):535-42. doi: 10.1177/030089161209800501. Tumori. 2012. PMID: 23235746 Review.
Safety of eribulin mesylate and concomitant radiotherapy for metastatic breast cancer: a single-center experience.
Meattini I, Desideri I, Di Cataldo V, Francolini G, De Luca Cardillo C, Scotti V, Loi M, Detti B, Mangoni M, Agresti B, Baldazzi V, Greto D, Casella D, Bernini M, Sanchez LJ, Orzalesi L, Nori J, Fambrini M, Bianchi S, Livi L. Meattini I, et al. Among authors: di cataldo v. Future Oncol. 2016 May;12(9):1117-24. doi: 10.2217/fon-2015-0059. Epub 2016 Mar 9. Future Oncol. 2016. PMID: 26956105
Killing two birds with a stone: how to maximise benefit from metastasis-directed therapy and modern systemic treatment in oligometastatic hormone sensitive prostate cancer.
Francolini G, Di Cataldo V, Detti B, Simontacchi G, Loi M, Valzano M, Desideri I, Meattini I, Mangoni M, Livi L. Francolini G, et al. Among authors: di cataldo v. Clin Exp Metastasis. 2022 Dec;39(6):841-843. doi: 10.1007/s10585-022-10187-2. Epub 2022 Oct 15. Clin Exp Metastasis. 2022. PMID: 36242700
Predictive factors for tolerance to taxane based chemotherapy in older adults affected by metastatic prostate cancer (ANCHISES-NCT05471427): A prospective observational trial including patients with metastatic hormone sensitive and castrate resistant prostate cancer treated with taxane chemotherapy.
Francolini G, Frosini G, Di Cataldo V, Detti B, Carnevale MG, Banini M, Peruzzi A, Salvestrini V, Visani L, Olmetto E, Becherini C, Allegra A, Burchini L, Scotti V, Mangoni M, Meattini I, Desideri I, Livi L. Francolini G, et al. Among authors: di cataldo v. J Geriatr Oncol. 2023 Jan;14(1):101411. doi: 10.1016/j.jgo.2022.11.010. Epub 2022 Dec 8. J Geriatr Oncol. 2023. PMID: 36496347
Planning Automation for Treatment Techniques Comparison and Robustness Analysis: Tangential Intensity Modulated Radiation Therapy and Volumetric Modulated Arc Therapy for Whole Breast Irradiation.
Marrazzo L, Chilà D, Vanore I, Pellegrini R, Voet P, Di Cataldo V, Meattini I, Zani M, Arilli C, Calusi S, Casati M, Compagnucci A, Talamonti C, Livi L, Pallotta S. Marrazzo L, et al. Among authors: di cataldo v. Adv Radiat Oncol. 2025 Jan 15;10(3):101719. doi: 10.1016/j.adro.2025.101719. eCollection 2025 Mar. Adv Radiat Oncol. 2025. PMID: 40092157 Free PMC article.
Prognostic value of positive human epidermal growth factor receptor 2 status and negative hormone status in patients with T1a/T1b, lymph node-negative breast cancer.
Livi L, Meattini I, Saieva C, Franzese C, Di Cataldo V, Greto D, Franceschini D, Scotti V, Bonomo P, Nori J, Sanchez L, Vezzosi V, Bianchi S, Cataliotti L, Biti G. Livi L, et al. Among authors: di cataldo v. Cancer. 2012 Jul 1;118(13):3236-43. doi: 10.1002/cncr.26647. Epub 2011 Oct 25. Cancer. 2012. PMID: 22028054 Free article.
77 results